Clean up bullying investigations
We suggest that there should be an approved code of conduct for the investigation and reporting of complaints related to bullying, harassment and discrimination in the scientific workplace. Currently, the processing of such complaints can vary in objectivity and impartiality (see, for example, Nature 563, 304-305; 2018 and Nature 563, 616-618; 2018) .
The system needs to be tightened up and transparency improved. Organizations should not be allowed to protect their image -for instance, by shutting down a complaint too quickly. Investigations need to be genuinely independent, not conducted by single individuals from private employment-law firms in the pay of the institution. And tactics must never be used to silence complainants.
In our view, anti-bullying policies will not work until a clear code of conduct is in place to prevent manipulation of the investigation process and to ensure transparent and unbiased reporting to funding institutions (see also Nature 557, 149; 2018 
Avoid surgical brain contamination
In their paper on the likely transmission of potentially harmful amyloid-β protein aggregates to people given human pituitary growth hormone, Silvia Purro and colleagues close with a plea to improve methods for removing such contaminants from surgical instruments (Nature 564, 415-419; 2018) .
In Germany, precautionary measures to reduce unrecognized risks from protein 'seeds' are already recommended. Guidelines from the Commission for Hospital Hygiene and Infection Prevention highlight the importance of removing protein contaminations and of at least partially inactivating prions on surgical instruments (see go.nature.com/2vjyysf).
This approach can also protect against the accidental transfer of amyloid-β protein seeds (see, for example, M. Beekes and A. Thomzig Nature 531, 580; 2016). It could therefore be applied to all instruments at risk of such contamination, not just those used in brain surgery. Michael Beekes, Martin Mielke, Achim Thomzig Robert Koch Institute, Berlin, Germany. beekesm@rki.de
Manufacturers must make data accessible
The UK Biobank database contains health data from more than half a million people. It is an invaluable resource for understanding diseases and developing predictive machinelearning algorithms (see also Nature 562, 163-164; 2018) . In our experience, however, proprietary data formats by manufacturers of medical equipment are obstructing the sharing of clinical data.
In ophthalmology, for example, the Eye and Vision consortium has collected data for more than 100,000 individuals from the UK Biobank data set -one of the largest annotated data sets available. Unfortunately, a key data modality -from optical coherence tomography (OCT) -is inaccessible. It is present only in a proprietary format that is defined by the manufacturer of the OCT machine.
We obtained approval to 
